Zynex engineers, manufactures, markets and sells its own design of FDA cleared medical devices into two distinct markets standard electrotherapy products for pain relief / pain management, and the NeuroMove(TM) for stroke and spinal cord injury ("SCI") rehabilitation.
All Zynex products are intended to be patient friendly and designed for home use. The products are cost effective when compared to traditional physical therapy, and often result in better mobility, less pain and increased potential for a patient to return to work and a fuller life significantly earlier than with traditional therapies alone. The NeuroMove has been the subject of nine successfully completed clinical trials and is currently being evaluated in four additional trials
